Through our studies, a subset of cancer‐associated KEAP1 mutations was found to disrupt the substrate‐recruiting function of Kelch domain to impair the ability of KEAP1 to bind and promote SOX9 poly‐ubiquitination and degradation. Here, SOX9 is linked to cancer.